AU Patent

AU2008228941B2 — Compositions and methods for treating, reducing, ameliorating, or preventing infections caused by antibacterial drug-resistant bacteria

Assigned to Bausch and Lomb Inc · Expires 2011-12-01 · 14y expired

What this patent protects

Compositions comprise a fluoroquinolone having Formulae I-VIII for treating, reducing, ameliorating, or preventing infections caused by some bacteria that are resistant to an antibacterial drug. Methods for treating, reducing, ameliorating, or preventing such infections use such …

USPTO Abstract

Compositions comprise a fluoroquinolone having Formulae I-VIII for treating, reducing, ameliorating, or preventing infections caused by some bacteria that are resistant to an antibacterial drug. Methods for treating, reducing, ameliorating, or preventing such infections use such compositions.

Drugs covered by this patent

besifloxacin-hydrochloride (BESIFLOXACIN HYDROCHLORIDE)

Patent Metadata

Patent number: AU2008228941B2
Jurisdiction: AU
Classification: —
Expires: 2011-12-01
Drug substance claim: No
Drug product claim: No
Assignee: Bausch and Lomb Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.